These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 36964478)
1. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients. Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma. Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J Front Immunol; 2022; 13():922315. PubMed ID: 35774794 [TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C Front Immunol; 2021; 12():783362. PubMed ID: 35154072 [TBL] [Abstract][Full Text] [Related]
4. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
5. Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma. Huang L; Zhang J; Gong F; Han Y; Huang X; Luo W; Cai H; Zhang F Front Genet; 2022; 13():927142. PubMed ID: 36226186 [No Abstract] [Full Text] [Related]
6. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma. Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y Front Surg; 2022; 9():860806. PubMed ID: 35937602 [TBL] [Abstract][Full Text] [Related]
7. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma. Guo S; Chen J; Yi X; Lu Z; Guo W Front Immunol; 2022; 13():985051. PubMed ID: 36248853 [TBL] [Abstract][Full Text] [Related]
8. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma. Liu JW; Supandi F; Dhillon SK Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853 [TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma. Zhu J; Zhao Y; Wu G; Zhang X; Chen Q; Yang B; Guo X; Ji S; Gu K Oxid Med Cell Longev; 2022; 2022():7465880. PubMed ID: 35903713 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma. Chen X; Tu J; Ma L; Huang Y; Yang C; Yuan X Int J Gen Med; 2022; 15():3215-3235. PubMed ID: 35342303 [TBL] [Abstract][Full Text] [Related]
11. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia. Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730 [TBL] [Abstract][Full Text] [Related]
12. Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma. Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H Biomed Res Int; 2022; 2022():2056913. PubMed ID: 35937391 [TBL] [Abstract][Full Text] [Related]
13. Prediction of Prognosis and Molecular Mechanism of Ferroptosis in Hepatocellular Carcinoma Based on Bioinformatics Methods. Xiong Y; Ouyang Y; Fang K; Sun G; Tu S; Xin W; Wei Y; Xiao W Comput Math Methods Med; 2022; 2022():4558782. PubMed ID: 35774297 [TBL] [Abstract][Full Text] [Related]
14. A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma. Li G; Liu Y; Zhang Y; Xu Y; Zhang J; Wei X; Zhang Z; Zhang C; Feng J; Li Q; Wang G Front Immunol; 2022; 13():929089. PubMed ID: 35874689 [TBL] [Abstract][Full Text] [Related]
15. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y Front Immunol; 2021; 12():719175. PubMed ID: 34603293 [TBL] [Abstract][Full Text] [Related]
16. Prognostication of Pancreatic Cancer Using The Cancer Genome Atlas Based Ferroptosis-Related Long Non-Coding RNAs. Li J; Zhang J; Tao S; Hong J; Zhang Y; Chen W Front Genet; 2022; 13():838021. PubMed ID: 35237306 [No Abstract] [Full Text] [Related]
17. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma. Liu C; Liu Y; Yu Y; Zhao Y; Yu A BMC Med Genomics; 2022 Mar; 15(1):39. PubMed ID: 35232428 [TBL] [Abstract][Full Text] [Related]
18. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis. Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R Front Genet; 2022; 13():907331. PubMed ID: 35938001 [No Abstract] [Full Text] [Related]
19. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification. Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068 [TBL] [Abstract][Full Text] [Related]
20. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma. Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y Front Genet; 2021; 12():682082. PubMed ID: 34745200 [No Abstract] [Full Text] [Related] [Next] [New Search]